TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $597,096 | -81.6% | 71,423 | -45.4% | 0.01% | -83.1% |
| Q2 2023 | $3,246,439 | +78.6% | 130,694 | +8.1% | 0.07% | +61.4% |
| Q1 2023 | $1,818,140 | +21.5% | 120,887 | -4.4% | 0.04% | +4.8% |
| Q4 2022 | $1,495,809 | +188.8% | 126,442 | +1075.5% | 0.04% | +82.6% |
| Q1 2021 | $518,000 | -70.5% | 10,756 | -68.1% | 0.02% | -60.3% |
| Q4 2020 | $1,754,000 | +94.5% | 33,716 | +0.0% | 0.06% | +100.0% |
| Q3 2020 | $902,000 | +3.4% | 33,700 | -24.8% | 0.03% | +11.5% |
| Q2 2020 | $872,000 | +1306.5% | 44,788 | +303.3% | 0.03% | +2500.0% |
| Q3 2019 | $62,000 | – | 11,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |